报告
已发布: 5 五月 2025

Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia

Antimicrobial resistance (AMR) is a deadly global crisis, linked to 4.71 million deaths in 2021 and projected to rise to 8.22 million annually by 2050 – surpassing cancer as the leading cause of death. Asia stands at the epicentre of this threat, driven by overuse of antibiotics, weak health systems, poor sanitation and climate vulnerabilities.

Antimicrobial resistance (AMR) is a deadly global crisis, linked to 4.71 million deaths in 2021 and projected to rise to 8.22 million annually by 2050 – surpassing cancer as the leading cause of death. Asia stands at the epicentre of this threat, driven by overuse of antibiotics, weak health systems, poor sanitation and climate vulnerabilities.

This paper outlines a strategic response grounded in three urgent “sprints” – educate, prevent and monitor; and a long-term “marathon” – to treat AMR through R&D and equitable access to medicines. From responsible antibiotic use to improved diagnostics and sanitation systems, strategic investment in the Asia-Pacific could save up to $55 billion annually by the next decade. This paper by the World Economic Forum’s Giving to Amplify Earth Action (GAEA) initiative, Centre for Impact Investing and Practices (CIIP) and Philanthropy Asia Alliance (PAA) aims to inform and encourage private funders, impact investors and philanthropists to support the fight against AMR.

许可和重新发布

世界经济论坛 报告 可依照 知识共享 署名-非商业性-非衍生品 4.0 国际公共许可协议 ,并根据我们的 使用条款 重新发布。

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛